IMAX (IMAX) PT Raised to $45 at Stifel on China Listing

Stifel analyst Benjamin Mogil reiterated a Buy rating and raised his price target on IMAX Corporation (NYSE: IMAX) to $45.00 (from $40.00) following incremental disclosures on the listing of its Chinese subsidiary on the Hong Kong exchange.

"We view its share of box office and the increase in the zones in the market as incrementally positive," Mogil states. "We note that our valuation for the segment is still well below comparables listed in China. We remain Buy rated."

For an analyst ratings summary and ratings history on IMAX Corporation click here. For more ratings news on IMAX Corporation click here.

Shares of IMAX Corporation closed at $38.77 yesterday.

You May Also Be Interested In

• Chipotle Mexican Grill (CMG) PT Raised to $3,050 at Stephens
• Humana (HUM) PT Lowered to $353 at RBC Capital
• Boston Scientific (BSX) PT Raised to $84 at Baird